BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8690223)

  • 1. "Kapping" visceral pain in patients with irritable bowel syndrome: does it work?
    Pasricha PJ
    Gastroenterology; 1996 Aug; 111(2):531-3. PubMed ID: 8690223
    [No Abstract]   [Full Text] [Related]  

  • 2. The kappa agonist fedotozine relieves hypersensitivity to colonic distention in patients with irritable bowel syndrome.
    Delvaux M; Louvel D; Lagier E; Scherrer B; Abitbol JL; Frexinos J
    Gastroenterology; 1999 Jan; 116(1):38-45. PubMed ID: 9869600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Visceral sensitivity and functional bowel disorders: physiopathological role and therapeutic perspectives].
    Delvaux M; Frexinos J
    Gastroenterol Clin Biol; 2001 Sep; 25(2 Pt 2):C42-53. PubMed ID: 11787379
    [No Abstract]   [Full Text] [Related]  

  • 4. [Functional colonic diseases: from physiopathology to pharmacology].
    Bardou M
    Rev Med Interne; 1999 Feb; 20(2):151-7. PubMed ID: 10227093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacology and clinical experience with fedotozine.
    Delvaux M
    Expert Opin Investig Drugs; 2001 Jan; 10(1):97-110. PubMed ID: 11116283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visceral analgesia: an emerging concept for managing functional gastrointestinal disease.
    Hasler WL
    Gastroenterology; 1998 Oct; 115(4):1023-4. PubMed ID: 9786728
    [No Abstract]   [Full Text] [Related]  

  • 7. New drugs in the management of the irritable bowel syndrome.
    Farthing MJ
    Drugs; 1998 Jul; 56(1):11-21. PubMed ID: 9664195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Functional intestinal disorders and quality of life].
    Chassany O; Bergmann JF
    Gastroenterol Clin Biol; 2001 Sep; 25(2 Pt 2):C54-62. PubMed ID: 11787380
    [No Abstract]   [Full Text] [Related]  

  • 9. Fedotozine blocks hypersensitive visceral pain in conscious rats: action at peripheral kappa-opioid receptors.
    Langlois A; Diop L; Friese N; Pascaud X; Junien JL; Dahl SG; Rivière PJ
    Eur J Pharmacol; 1997 Apr; 324(2-3):211-7. PubMed ID: 9145774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Today's therapy of functional gastrointestinal disorders--does it help?
    Berstad A
    Eur J Surg Suppl; 1998; (583):92-7. PubMed ID: 10027681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of peripheral kappa agonist fedotozine versus placebo in treatment of irritable bowel syndrome. A multicenter dose-response study.
    Dapoigny M; Abitbol JL; Fraitag B
    Dig Dis Sci; 1995 Oct; 40(10):2244-9. PubMed ID: 7587797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacy of alverina citrate and simethicone combination in abdominal pain and discomfort of irritable bowel syndrome].
    Wittmann T; Paradovsky L; Ducrotte P; Bueno L; Andro-Delestrain MC
    Eksp Klin Gastroenterol; 2011; (3):60-7. PubMed ID: 21698811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Old and new physiopathological concepts of irritable bowel syndrome].
    Fioramonti J; Bueno L; Delvaux M; Frexinos J
    Gastroenterol Clin Biol; 2001 Sep; 25(2 Pt 2):C34-41. PubMed ID: 11787378
    [No Abstract]   [Full Text] [Related]  

  • 14. [Irritable bowel syndrome: pathophysiology and (future) treatment options].
    Grooff B
    Ned Tijdschr Geneeskd; 2002 Mar; 146(11):540; author reply 540. PubMed ID: 11925818
    [No Abstract]   [Full Text] [Related]  

  • 15. Why do we hiccup?
    Kahrilas PJ; Shi G
    Gut; 1997 Nov; 41(5):712-3. PubMed ID: 9414986
    [No Abstract]   [Full Text] [Related]  

  • 16. Adequate relief as an endpoint in clinical trials in irritable bowel syndrome.
    Mangel AW; Hahn BA; Heath AT; Northcutt AR; Kong S; Dukes GE; McSorley D
    J Int Med Res; 1998; 26(2):76-81. PubMed ID: 9602985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Irritable bowel syndrome: pathophysiology and (future) treatment options].
    de Schryver AM; Samsom M
    Ned Tijdschr Geneeskd; 2002 Jan; 146(1):12-7. PubMed ID: 11802330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symptom expression in pain-predominant functional bowel syndrome: is visceral hyperalgesia the whole truth?
    Shapiro MS; Olden KW
    Am J Gastroenterol; 2000 Apr; 95(4):862-3. PubMed ID: 10763924
    [No Abstract]   [Full Text] [Related]  

  • 19. Pathogenesis of irritable bowel syndrome.
    Barbara L; Baldi F; Longanesi A
    Ital J Gastroenterol; 1991 Nov; 23(8 Suppl 1):36-8. PubMed ID: 1756280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mechanism of action of trimebutine maleate on gastro-colic reflex in patients with irritable bowel syndrome].
    Matsue T; Yamato S; Umeda N
    Nihon Heikatsukin Gakkai Zasshi; 1990 Apr; 26(2):89-92. PubMed ID: 2273694
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.